LONG-TERM COST-EFFECTIVENESS OF TICAGRELOR IN PATIENTS WITH ACUTE CORONARY SYNDROME IN THAILAND

被引：0
|
作者：
Permsuwan, U. [1 ]
Yamwong, S. [2 ]
Tinmanee, S. [3 ]
Sritara, P. [2 ]
机构：
[1] Chiang Mai Univ, Chiang Mai 50000, Thailand
[2] Mahidol Univ, Ramathibodi Hosp, Bangkok 10700, Thailand
[3] AstraZeneca Thailand Ltd, Bangkok, Thailand
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.196
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A633 / A633
页数：1
相关论文
共 50 条
  • [21] Cost-effectiveness of ticagrelor versus clopidogrel for the prevention of atherothrombotic events in adult patients with acute coronary syndrome in Germany
    Theidel, Ulrike
    Asseburg, Christian
    Giannitsis, Evangelos
    Katus, Hugo
    CLINICAL RESEARCH IN CARDIOLOGY, 2013, 102 (06) : 447 - 458
  • [22] Cost-effectiveness of ticagrelor versus clopidogrel for the prevention of atherothrombotic events in adult patients with acute coronary syndrome in Germany
    Ulrike Theidel
    Christian Asseburg
    Evangelos Giannitsis
    Hugo Katus
    Clinical Research in Cardiology, 2013, 102 : 447 - 458
  • [23] Cost-Effectiveness of Ticagrelor Compared with Clopidogrel in Patients with Acute Coronary Syndrome from Vietnamese Healthcare Payers’ Perspective
    Thuy Thi Thu Nguyen
    Dung Van Do
    Carl Mellstrom
    Tuan Quang Nguyen
    Hung Manh Pham
    Sy Van Hoang
    Thinh Cong Luu
    Tri Le Phuong
    Advances in Therapy, 2021, 38 : 4026 - 4039
  • [24] Cost-Effectiveness of Ticagrelor Compared with Clopidogrel in Patients with Acute Coronary Syndrome from Vietnamese Healthcare Payers' Perspective
    Thuy Thi Thu Nguyen
    Dung Van Do
    Mellstrom, Carl
    Tuan Quang Nguyen
    Hung Manh Pham
    Sy Van Hoang
    Thinh Cong Luu
    Tri Le Phuong
    ADVANCES IN THERAPY, 2021, 38 (07) : 4026 - 4039
  • [25] Cost-effectiveness of treating acute coronary syndrome patients with ticagrelor for 12 months: results from the PLATO study
    Nikolic, Elisabet
    Janzon, Magnus
    Hauch, Ole
    Wallentin, Lars
    Henriksson, Martin
    EUROPEAN HEART JOURNAL, 2013, 34 (03) : 220 - 228
  • [26] COST-EFFECTIVENESS OF TICAGRELOR COMPARED WITH CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME FROM A VIETNAMESE HEALTHCARE PAYERS' PERSPECTIVE
    Do, V. D.
    Nguyen, T. T.
    Mellstrom, C.
    Nguyen, Q. T.
    Pham, M. H.
    Hoang, V. S.
    Phuong, L. T.
    Luu, T. C.
    VALUE IN HEALTH, 2018, 21 : S2 - S2
  • [27] COST EFFECTIVENESS OF TICAGRELOR IN THE TREATMENT OF ACUTE CORONARY SYNDROME IN GERMANY
    Theidel, U.
    Asseburg, C.
    Giannitsis, E.
    Katus, H.
    VALUE IN HEALTH, 2011, 14 (07) : A376 - A377
  • [28] LONG-TERM COST-EFFECTIVENESS ANALYSIS OF TICAGRELOR IN PATIENTS WITH ACUTE CORONARY SYNDROME (ACS) FROM A MEXICAN PUBLIC AND PRIVATE HEALTH CARE PERSPECTIVE BASED ON DATA FROM THE PLATO TRIAL
    Garcia-Castillo, A.
    De-los-Rios, M.
    Polanco, A. C.
    Ramirez, M. A.
    Nikolic, E.
    Mellstrom, C.
    VALUE IN HEALTH, 2011, 14 (07) : A379 - A380
  • [29] COST-EFFECTIVENESS OF TICAGRELOR VERSUS GENERIC CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES IN CANADA
    Grima, D. T.
    Brown, S. T.
    Kamboj, L.
    Bainey, K.
    Goeree, R.
    Oh, P.
    Ramanathan, K.
    Goodman, S.
    VALUE IN HEALTH, 2013, 16 (03) : A285 - A285
  • [30] COST-EFFECTIVENESS OF ATORVASTATIN IN ACUTE CORONARY SYNDROME PATIENTS IN THE NETHERLANDS
    Thurston, S. J.
    Webb, K.
    Ong, S.
    Meerding, W. J.
    van Hout, B. A.
    VALUE IN HEALTH, 2009, 12 (07) : A335 - A335
12345